ISAPS Applauds US FDA Allowance of Textured-Surface Breast Implant Sales

The American Food and Drug Administration (FDA) issued a statement recently in regards to the March 2019 public advisory hearing on breast implants and the related risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).